Proof of Vaccination as Defined in the COVID-19 Protective Measures Exemption Directive and the Directive on Coronavirus Entry Regulations

As of 15 January 2022, the following criteria apply to proof of vaccination as defined in the COVID-19 Protective Measures Exceptions Ordinance (SchAusnahmV) and the Coronavirus Entry Ordinance (CoronaEinreiseV).

Changes to the criteria will be posted here as soon as reasonably possible.

Pursuant to section 2 sentence 3 of the SchAusnahmV and section 2 sentence 10 of the CoronaEinreiseV, proof of complete vaccination protection against the coronavirus SARS-CoV-2 exists if the underlying vaccinations correspond to the requirements published by the Paul-Ehrlich-Institut. These requirements, published in consultation with the Robert Koch-Institut and taking currently available medical information into account, must be met with respect to the following criteria:

• a) the vaccine used,
• b) the number of individual vaccinations required for complete vaccination protection,
• c) any booster vaccinations required for continued full vaccination protection,

• d) the length of time

  • a) that must pass after vaccination for complete vaccination protection and
  • b) that must not be exceeded between individual vaccinations and booster vaccinations.

The following vaccines can be used in the following combinations for full vaccination protection.

Requirements for full vaccination protection with a vaccine

Requirements for complete vaccination protection with different vaccines (heterologous vaccination schedule)

List of marketing authorisations and vaccine product names in third countries (outside the EU and EEA)

Versions of EU-authorised vaccines authorised abroad (original or licensed productions) are equivalent to the named EU-authorised vaccines as proof of vaccination protection. For more information, please refer to the list below.

List of authorisations and vaccine product names in third countries (outside the EU and EEA) - As of 21 December 2021

The list is provided for informational purposes and does not claim to be complete. The person wishing to enter the country is responsible for providing proof of complete vaccination protection with a recognized, EU-authorised vaccine as defined by the Ordinance on Coronavirus Entry Regulations.

Time interval after vaccination for complete vaccination protection

Fourteen days must have passed since the last required vaccination in order for the vaccination to be considered complete.

Exceptional circumstances justifying full vaccination protection with a single dose of vaccine

Notwithstanding the requirements above, a single dose of vaccine with any of the vaccines listed above is considered sufficient if

• the person concerned has physical or digital proof in German, English, French, Italian or Spanish of a positive antibody test carried out on them and this test was carried out at a time when the person concerned had not yet received a vaccination against COVID-19. The laboratory diagnostic findings must have come from a laboratory that works in accordance with the guidelines of the German Medical Association on Quality Assurance in Medical Laboratory Examinations (RiLiBÄK) or that is accredited in accordance with DIN EN ISO 15189. In this case, the 14-day post-vaccination period does not apply.
• the person concerned has proof of a previous infection with the SARS-CoV-2 coronavirus. Proof of infection requires proof of a test based on laboratory diagnostics using nucleic acid detection laboratory diagnostics (PCR, POC-PCR or other nucleic acid amplification technology methods) and this test must have been carried out at a time when the person concerned had not yet been vaccinated against COVID-19. If the infection occurred before the first vaccination was given, the required 14-day post vaccination period does not apply.
• the person concerned was infected with the SARS-CoV-2 coronavirus after receiving a single vaccine dose. Proof of infection requires proof of a test based on laboratory diagnostics using nucleic acid detection (PCR, POC-PCR or other nucleic acid amplification technology methods). If the infection occurred after the first vaccine dose was administered, 28 days must have passed since the infection was first detected.

Note

Information on booster vaccinations and the corresponding time intervals has not yet been published.

As of

15 January 2022